Reporting of adverse events ONLY

Patients should always seek the advice of a doctor or pharmacist in case of adverse events.

If you wish to report an adverse event to ELC Group s.r.o., please find the contact information below:

+420 224 910 672

(from 09.00-17.30 CET)

+420 226 251 459

(non-stop 24/7)

To contact us about any other issue please call:

+420 22 491 0000or our regional offices.

Hlášení nežádoucích príhod

Pacienti by meli vždy požádat o radu svého lékare nebo lékárníka v prípade výskytu nežádoucích príhod.

Pokud chcete nahlásit nežádoucí príhodu spolecnosti ELC Group s r.o., prosím využijte kontaktních údaju níže:

+420 224 910 672

(09.00-17.30 CET)

+420 226 251 459

(non-stop 24/7)

Pro záležitosti, které se netýkaji farmakovigilance, kontaktujte prosím recepci:

+420 22 491 0000 nebo naše další pobočky.

DMF Filing in China

Date: 15.04.2021

Time: 10:30 AM CEST

Price: Free of charge

On Thursday 15th April, 2021, at 10:30 CEST (Central European Summer Time, UTC+ 2), ELC will be hosting a webinar providing an overview of DMF filing in China.

The presenters will be Mr. Chetan Javia, Senior Expert of Strategic Alliance & Regulatory Affairs from ELC Group, and Mr. Raymond Ng, Business Development Director from Accestra Consulting.

We are going to take you through the following topics:

  1. Regulatory Framework & Registration
  2. Comparison among China, EU & US
  3. Common Challenges
  4. Questions and Answers


To participate, please fill in the form below. You will then receive an invitation to this webinar. Please note that the number of participants is limited.